Kernal Biologics is listed on Rocketlist with 3 active roles. The company is categorized as mRNA Therapeutics in BioTech. Kernal Biologics is at Series A stage, with a B2B business model, headquartered in Cambridge, United States. Kernal Biologics was founded in 2016 and has 25 employees. Kernal Biologics has raised $73M. Active roles are refreshed daily from public hiring sources.